Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

Abbreviated MRI could become standard of care for prostate cancer diagnosis
Biparametric prostate MRIs take significantly less time than multiparametric exams, as they do not include a contrast-enhanced sequence. This also makes the abbreviated exams more cost-friendly.
Late-stage prostate cancer diagnoses on the rise
Experts say these new findings highlight the need for more effective screening initiatives among men who may face access barriers.
Surgeons can 'hear' cancerous lesions with help of new dual-mode radiotracer
When used during surgery, it can help providers identify cancerous lesions that are not in their immediate vision.
Shine working toward U.S. production of Mo-99 for SPECT imaging
Greg Piefer, PhD, chief executive and founder of SHINE, a Wisconsin-based radiopharmaceutical company that is building the world’s largest medical isotope production facility in Janesville, Wisconsin, explains progress on the company's fusion reactor that will become the first U.S. commercial supplier of molybdenum-99 in decades.
New radioummonotherapy may be more effective at treating ovarian cancer than current standard of care
The method targets cancer stem cells, which are highly tumorigenic and known to play a significant role in relapse, cancer spread and treatment resistance.

Abbreviated MRI could become standard of care for prostate cancer diagnosis

Biparametric prostate MRIs take significantly less time than multiparametric exams, as they do not include a contrast-enhanced sequence. This also makes the abbreviated exams more cost-friendly.

Late-stage prostate cancer diagnoses on the rise

Experts say these new findings highlight the need for more effective screening initiatives among men who may face access barriers.

Dual-mode radiotracer helps surgeons 'hear' invisible cancer lesions

Surgeons can 'hear' cancerous lesions with help of new dual-mode radiotracer

When used during surgery, it can help providers identify cancerous lesions that are not in their immediate vision.

Molecular Imaging PET and SPECT sign in GE booth ACC23.

Shine working toward U.S. production of Mo-99 for SPECT imaging

Greg Piefer, PhD, chief executive and founder of SHINE, a Wisconsin-based radiopharmaceutical company that is building the world’s largest medical isotope production facility in Janesville, Wisconsin, explains progress on the company's fusion reactor that will become the first U.S. commercial supplier of molybdenum-99 in decades.

New radioummonotherapy may be more effective at treating ovarian cancer than current standard of care

The method targets cancer stem cells, which are highly tumorigenic and known to play a significant role in relapse, cancer spread and treatment resistance.

Philips UroNav system gains FDA clearance

FDA clears fusion image navigation system for prostate cancer therapy planning

The fusion technology integrates pre-procedural MR images of the prostate with intraprocedural ultrasound images in real-time.

Bacteria-based contrast agent lights up tumor margins significantly better than other agents.

Bacteria-based contrast agent offers 'substantial improvements' for tumor border delineation during surgery

Essentially, the agent places a bright neon sign on the entirety of tumors and their borders, and it does so autonomously.

AI ups detection of small prostate lesions by nearly 20%

Many experts believe that artifcial intelligence could help address issues with reader variability on prostate MRIs.